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Abstract 
Background: One of the major factors contributing to parental refusal of vaccinations is the 
perception that vaccines cause side-effects. While symptoms are commonly reported 
following vaccinations, their causes are not always straightforward. Although some may be 
directly attributable to the vaccine itself, others may reflect pre-existing or coincidental 
symptoms that are misattributed to the vaccine. 
Purpose: To investigate psychological factors associated with parental report of side-effects 
following vaccination with the child influenza vaccine, and parental intention to re-vaccinate 
one’s child the following year. 
Methods: A prospective cohort study was run in primary care practices in London in the 
2016/17 influenza season (ClinicalTrials.gov number NCT02909855). 270 parents from 
fourteen practices completed a questionnaire before their child’s vaccination. Follow-up 
questionnaires were completed three days after vaccination and one month after vaccination. 
Parental report of side-effects and vaccination intention for the subsequent year were 
measured. 
Results: Parental report of side-effects was strongly associated with pre-vaccination 
expectation of side-effects. Suggestions received from the media, NHS vaccination leaflet 
and health care workers, as well as uncertainty-related beliefs, perceived sensitivity of the 
child to medicines, pessimism and anxiety were also associated with reporting side-effects. 
Side-effect report was associated with lower vaccination intention for the following influenza 
season. 
Conclusions: Side-effect perception following vaccination is influenced by psychological 
factors, in particular expectations. Perceiving side-effects reduces future vaccination 
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intention. Future public health communications should aim to decrease unrealistic 
expectations of side-effects in order to increase vaccine uptake. 
Key words: influenza, child vaccination, attitudes, symptom, psychological factors  
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Introduction 
In England, routine vaccination of children for influenza began in 2013 (1). Although the 
vaccine is provided for free, uptake remains low, with vaccination targets of 40% in two to 
four year olds set by Public Health England not being reached in the 2015/16 and 2016/17 
influenza seasons (2, 3). There has been much research conducted on factors associated with 
vaccine uptake, with a number of systematic reviews consistently finding the perception that 
the vaccine causes side-effects to be associated with vaccination refusal (4-7). 
Although side-effects from the influenza vaccine are mostly “mild in nature and short term” 
(8), research by our group indicates that parents who perceived side-effects in their child 
following vaccination for influenza in the 2015/16 season were less likely to intend to re-
vaccinate their child the following year (9). This issue is particularly problematic for the child 
influenza vaccine as clinical trial data indicate that 47.9% of children will experience side-
effects following vaccination (8), yet children need to be re-vaccinated each year.  
To date, there has been little research exploring the factors that contribute to parental 
perception of side-effects in one’s child. Understanding what determines whether parents 
perceive symptoms in their child has implications not just for our understanding of how their 
attitudes towards vaccinations develop, but also for our understanding of treatment decisions 
made on behalf of the child more generally (10) and on the burden to health care services if 
parents overestimate the presence or severity of a symptom (9, 11). 
Research has identified associations between a number of psychological factors and symptom 
perception in oneself. One study, investigating the incidence of side-effects following travel 
vaccinations, found that adults who were already symptomatic at the time of vaccination 
reported more symptoms following vaccination (12). Symptom perception in oneself has also 
been associated with perceived sensitivity to medicines (12, 13), modern health worries (14-
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19) and personality traits such as anxiety (20) and negative affect (12, 21, 22). Increases in 
symptom reports have been shown following news coverage about the side-effects of a 
medication (23) and following observation of symptoms in others (24), something which may 
be more apparent in females than in males (24, 25). Negative beliefs about medicines are 
associated with higher expectations of side-effects (26) and misattribution of nonspecific 
symptoms to medications (27). For some of these factors, the potential for a vicious circle 
exists. For example, if perceived sensitivity to medicines facilitates the development of 
symptoms after a medicine is taken, this may reinforce a patient’s view of themselves as 
sensitive.  
In contrast to what we know about perception of symptoms in oneself, limited, mainly poor 
quality research exists investigating parental perception of symptoms in one’s child. Studies 
suggest that some factors associated with symptom perception in the self may also be 
implicated in parental perception of symptoms. For example, parental symptom perception 
has been associated with an expectation for medication to cause side-effects (28, 29), and 
social observation of symptoms in others (9). General attitudes, such as being concerned 
about the safety of a vaccine and not liking vaccinations for the child have also been 
associated with parental symptom perception (9, 30). Parents are more likely to perceive 
symptoms in their child if the child has a history of symptoms, or is currently experiencing 
nonspecific symptoms (31-37), or if the child has a chronic health problem (9, 35, 38-41). 
Parents with increased anxiety report more symptoms in their child (32-34, 42). However, 
almost all research investigating factors associated with the perception of symptoms in the 
child is cross-sectional, limiting our ability to infer causality. 
Although parents may perceive side-effects in their child immediately following their 
influenza vaccination (43), their decision to re-vaccinate their child occurs one year later. 
Recall of symptoms is often inaccurate, and may be influenced by different factors to 
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immediate perception, including expectation, previous experiences and symptom severity 
(44).  
In this study, we sought to: a) assess whether pre-vaccination symptoms, parental 
expectation, previous history of symptoms following vaccination, parental psychological 
traits, parental perceptions about medicines and other technologies, attitudes towards 
influenza and the vaccine, and personal and clinical characteristics are associated with 
parental report of side-effects following child influenza vaccination both immediately after 
and one month after vaccination; b) identify whether the influence of significant predictors on 
perception of side-effects is mediated by parental expectations; and c) assess whether 
perception of a side-effect, worry about and perceived severity of side-effects, suggestion of 
side-effects from a health care worker, and change in the child’s perceived sensitivity to 
medicines is associated with vaccination intention for the following influenza season. We 
also hypothesised that perception of side-effects might affect parental perception of their 
child’s sensitivity to medicines. 
Methods 
Design 
Participants in this prospective cohort study completed questionnaires before their child 
received the influenza vaccine for the 2016/17 influenza season (T1), three days after their 
vaccination (perception, T2) and one month after their vaccination (recall, T3). 
Sample size calculation 
We based our sample size calculation on the ability to detect a small odds ratio of 1.6 (45) for 
symptom perception between parents with high and low expectation of symptoms. Clinical 
trial data suggest that 47.9% of children who received the Fluenz tetra vaccine report a 
symptom (46). Survey data by our group suggested that we could assume equal sample sizes 
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between those who do and do not expect symptoms (47). To detect this difference as 
significant at the 5% level with 85% power requires a total sample size of 180. We therefore 
aimed to recruit 300 people at T1, to allow for a 40% attrition rate.   
Participants and recruitment 
Participants were eligible for the study if they: had a child aged two to four on 31st August 
2016; were 18 years or over; and spoke fluent English. 
Potential participants were identified by eleven primary care practices in South London and 
were sent letters informing them about the study. Parents were then approached upon arrival 
at the practice for their child’s influenza vaccination by LS or a research nurse. Additional 
participants from other practices participated online. 
Study materials 
Full study materials can be found in the supplementary materials. 
Outcome measures 
We asked parents at T2 and T3 if they thought their child had “experienced any of the 
following side-effects because of their latest child flu vaccine.” For our list of side-effects, we 
used an adapted parent-report form of the patient health questionnaire (48), to which were 
added potential side-effects of the vaccine listed in the patient information leaflet (46) and a 
more general non-specific symptom (the child being “not themselves”) that was 
recommended when the materials were piloted with 11 parents. This symptom list has been 
used in a previous nationally-representative study by our group (9).  
Intention to vaccinate in the 2017/18 influenza season was measured at T2 and T3 by two 
items adapted from Payaprom et al. (49) (“I want [child] to be vaccinated for flu next year” 
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and “I intend [child] to be vaccinated for flu next year”) which were rated on a five-point 
Likert scale from “strongly disagree” to “strongly agree.”  
Symptoms prior to vaccination 
A child’s existing symptoms at the time of vaccination were measured by asking parents if 
their child had “shown signs of any of the following symptoms in the last 24 hours.” The list 
of symptoms provided was the same as that used in our outcome measure.  
Expectation 
A direct measure of expectation asked parents how likely it was that their child would “get 
short term side-effects from the flu vaccine” on a five-point Likert scale of “very unlikely” to 
“very likely.” Parents were also asked how likely five different sources (friends and family, 
official websites and departments, the media, the NHS influenza vaccination leaflet, and the 
health care worker) had said side-effects were from the vaccine, and their trust in these 
sources of information. Parents were also asked whether they knew “any children who have 
experienced side-effects from the flu vaccine.” All expectation questions were asked at T1 
apart from those relating to the suggestion of side-effects from the heath care worker as these 
could not be asked until after the vaccination appointment had taken place, at T2. 
Symptoms following previous vaccinations 
At T1, parents were asked if the child had “ever had side-effects” from previous influenza 
vaccinations and other routine vaccinations. Parents who indicated their child had 
experienced side-effects from previous influenza vaccinations were asked how severe the 
side-effects were and how worried they had been. Parents who indicated their child had 
experienced side-effects from other routine childhood vaccinations were asked how worried 
they had been.  
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Psychological traits 
Participants completed four personality measures at T2. Participants’ trait anxiety was 
measured by the short form of the State-Trait Anxiety Inventory (STAI-T) (50). Trait affect 
was measured using the short form Positive and Negative Affect Schedule (PANAS) (51). 
Participants’ neuroticism was measured using the neuroticism items from an abbreviated 
form of the Eysenck Personality Questionnaire – Revised (EPQR-A) (52). Optimism and 
pessimism were measured using the revised Life Orientation Test (LOT-R) (53).  
Perceptions about other medicines and technologies 
Participants’ perception of their child’s sensitivity to medicines was measured at both T1 and 
T3 using an adapted parental report version of the Perceived Sensitivity to Medicines 
questionnaire (PSM) (13).  
The Modern Health Worries Questionnaire (MHW) (54) and the Beliefs about Medicines 
Questionnaire, general section (BMQ-G) (55) were both completed at T2. 
Attitudes towards influenza and the vaccine 
Attitudes towards influenza and the child influenza vaccine were measured at T1 by a series 
of fifteen statements used in a previous study by our group (9). Parents were also asked how 
much it would impact their daily life if their child were to catch influenza. 
Personal and clinical characteristics  
Participants were asked for their age and gender. Personal characteristics relating to the index 
child included age, gender and whether they were the parent’s first child. Clinical 
characteristics, such as whether the parent or child had a long-term health condition and 
whether there were any people ‘at risk’ for influenza in the child’s household were also 
asked. Participants were asked whether the child was up-to-date on other routine vaccines. 
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Procedure 
Ethical approval for the study was granted by the NHS Research Ethics Committee 
(Reference: IRAS ID: 192325, REC reference: 16/LO/1003). 
Participants were recruited into the study between 1st October 2016 and 16th December 2016. 
Prior to completing T1 materials, consent was obtained from all parents following standard 
practice from our research ethics committee. 
Parents completed T1 materials in the waiting room at the primary care practice immediately 
prior to their child’s vaccination appointment, or online before their child’s vaccination 
appointment. One item in T1, asking whether the child had experienced any symptoms in the 
past 24 hours, was excluded from the online version; participants were contacted on the day 
of their child’s vaccination appointment to answer this.  
Three days after the vaccination appointment, parents were contacted via email with a link to 
T2 materials, which were available online. One month after the vaccination appointment, 
parents were emailed a link to T3 task materials. If participants did not have access to email, 
T2 and T3 materials were completed by telephone. 
Protocol registration 
The protocol for the study was registered in advance on clinicaltrials.gov (identifier: 
NCT02909855). 
Data analysis 
Predictors of side-effect report 
We recoded report of a symptom at T2 or T3 and in the 24 hours prior to vaccination into 
binary variables (reported at least one symptom versus no symptoms reported).  
We recoded data where parents indicated that they had not received information from a 
particular source as missing. A composite measure of symptom suggestion from each 
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information source was created by multiplying the suggestion of side-effects from that source 
by the participant’s trust in that source. We treated knowing another child who had 
experienced side-effects following vaccination for influenza as a binary variable (yes, no). 
General attitude questions were recoded to binary variables (agree, disagree); as with 
previous research using these items, we treated “neither agree nor disagree” as missing data. 
Separate logistic regressions were used to determine whether pre-existing symptoms; 
expectation for the child to develop side-effects; previous experience of side-effects; 
personality traits; perceptions; attitudes; and personal and clinical characteristics predicted 
perception of side effects at T2 and T3.  
Expectations as a mediating variable 
Zero-order correlations were run to identify factors that were correlated with direct 
expectations of the child developing side-effects and side-effect report at T2 and T3. Factors 
that were correlated with both direct expectations and side-effect report at either T2 or T3 
were entered into mediation analyses using the method described in Mackinnon (56). 
Mediation using standardised coefficients was run to see whether the report of side-effects 
was mediated by expectation. 95% confidence intervals were computed using bootstrapping 
(2000 repetitions) and were bias-corrected. Personal and clinical characteristics were entered 
into the model as covariates. 
Predictors of vaccination intention 
Answers to vaccination intention questions were dichotomised, with participants coded as 
‘definitely intending’ to vaccinate their child (answered “agree” or “strongly agree” to both 
questions) or ‘not definitely intending’ to vaccinate (answered “neither agree nor disagree,” 
“disagree” or “strongly disagree” to one or both questions). We then used intention at both T2 
and T3 to create a single overall intention score. Where participants only completed one 
follow-up questionnaire we used the data available to us to classify their response as either 
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‘definitely intend’ or ‘do not definitely intend’ to vaccinate. Where participants completed 
both T2 and T3 and had concordant intentions, we classified them as either ‘definitely intend’ 
or ‘do not definitely intend’ as appropriate. If conflicting intentions were given at T2 and T3 
we classified participants as ‘do not definitely intend.’  
We computed the difference between perceived sensitivity to medicines at T3 and T1 by 
subtracting T1 scores from T3.  
Logistic regression analyses were used to identify whether report of a side-effect at T2 or T3; 
worry about and perceived severity of these side-effects; suggestion that the child would 
experience side-effects by a health care worker; and change in the child’s perceived 
sensitivity to medicines, predicted intention to re-vaccinate the child in the next influenza 
season.  
Predictors of change in perceived sensitivity  
We used linear regression analyses to identify whether reporting side-effects at T2 or T3 was 
associated with an increase in perceived sensitivity to medicines. For these analyses, 
perceived sensitivity to medicines at T1 was controlled for (57).  
Sensitivity analyses 
We ran sensitivity analyses to identify whether clustering by primary care practice affected 
the significance of any of the results. We used mixed models, including primary care practice 
as a random effect in the regressions. For mediation analyses, we followed the same approach 
to see if clustering affected pathways. 
All analyses controlled for personal and clinical characteristics and were run in SPSS version 
22 (58), apart from mediation analyses which were run in STATA 12 (59). The 
binary_mediation macro was used, which allows for dichotomous outcomes as well as taking 
covariates into account.  
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Results 
Participants 
270 participants were recruited from fourteen primary care practices. 233 participants 
initiated T2 follow-up, with 202 (74.8%; 185 mothers) participants completing all items. 200 
participants initiated T3 follow-up, with 195 (72.2%; 164 mothers) completing all items. 167 
participants (61.9%) completed both follow-ups. Participants’ personal characteristics can be 
found in Table 1.  
Side-effect reporting 
At T2, 98 people out of 227 who completed the question (43.2%, 95% CI [36.7, 49.7]) 
reported at least one side-effect. At T3, 72 people (out of 200, 36.0%, 95% CI [29.3, 42.7]) 
recalled at least one side-effect. Associations between personal characteristics, predictor 
variables and side-effect report can be found in Tables 1 to 3. 
At T2, parents were more likely to report side-effects in boys, if they had expected their child 
to experience side-effects and if they had perceived a suggestion of side-effects from the 
media, NHS vaccination leaflet or health care worker during their vaccination appointment. 
When taking into account both trust and suggestion, only suggestions from health care 
workers increased the odds of reporting side-effects. 
At T3, parents were more likely to recall that their child had experienced side-effects if they 
had expected side-effects; perceived a suggestion of side-effects from the NHS vaccination 
leaflet; had high trait anxiety; high pessimism; and if they perceived their child to be sensitive 
to medicines. Perceiving oneself not to know enough about the vaccine and feeling that the 
vaccine is not safe were also associated with the recall of side-effects at T3. 
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Expectation as a mediator 
When controlling for personal and clinical characteristics, there was an indirect effect of 
suggestion of side-effects from the media (β=.103, 95% CI [.005 to .251]; see Table 4) 
through expectation on side-effects reported at T2. There was also an indirect effect of 
suggestion of side-effects from the NHS vaccination leaflet (β=.143, 95% CI [.033 to .307]) 
through expectation on side-effects reported at T2. At T3, there was no evidence for an 
indirect effect of suggestion of side-effects from the NHS vaccination leaflet or pessimism 
through expectation, on recall of side-effects. There was, however, an indirect effect of 
perceived sensitivity to medicines through expectation on side-effects recalled (β=.098, 95% 
CI [.020 to .210]); the total effect of the mediation model was significant (β=.269, 95% CI 
[.060 to .460]), with 36.6% of the effect mediated. 
Intention to vaccinate 
204 (83.6%, 95% CI [78.9, 88.3]) parents indicated that they definitely intended to vaccinate 
their child in the next influenza season (2017/18), while 40 (16.4%, 95% CI [11.7, 21.1]) 
indicated that they did not definitely intend to vaccinate their child. Associations between 
personal characteristics, predictor variables and vaccination intention can be found in Tables 
5 and 6. 
Parent age was associated with intention, with parents aged 35 to 44 having higher 
vaccination intention. Parental worry about side-effects at T2 and perceived severity of side-
effects at T2 were also associated with decreased intention to vaccinate. At T3, parental recall 
that one’s child experienced a side-effect and worry about the side-effects were associated 
with decreased intention. 
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Perceived sensitivity to medicines 
At T1, the overall mean PSM score was 10.03 (SD=3.34, n=270), while at T3 it was 9.40 
(SD=3.36, n=194) (t(193)=1.264, p=.21). 
While there was no association between reporting side-effects at T2 and change in PSM 
score, a significant association was found at T3 (β=.20, t(183)=2.79, p=.006; see Table 7), 
with parents who recalled that their child experienced side-effects tending to increase their 
rating of their child’s perceived sensitivity to medicines. 
Sensitivity analyses 
Sensitivity analyses indicated that there were no substantial differences to the results when 
taking into account the effect of clustering by primary care practice. Only two results were 
changed: worry about side-effects at T3 was no longer significantly associated with intention 
to vaccinate; and side-effects recalled at T3 was no longer significantly associated with 
change in parental perceived sensitivity to medicines. For the mediation analyses, there was 
no difference to the strength or the significance of any of the main pathway effects. Thus, 
clustering should not change the results of the binary_mediation analysis macro. 
Discussion 
Concern about side-effects is a common reason for declining vaccination (4). This is a 
potential problem for the influenza vaccine for which side-effects are common and yearly 
vaccination is recommended. As might be expected in a cohort of parents who have already 
vaccinated their child once (5), most of our participants intended to vaccinate their child 
again the following year. However, one in six parents were less than certain in their 
intentions. Factors that strongly predicted being uncertain were the perceived severity and 
worry about side-effects three days after vaccination and recalling one month later that the 
child had experienced side-effects. These findings suggest that providing reassurance to 
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parents about the typically transitory and non-harmful nature of side-effects may be a useful 
strategy in reducing long-term attrition among parents who initially vaccinate their child. 
Pre-vaccination expectations were strongly associated with side-effect reporting both three 
days and one month after vaccination, indicating the stability of expectations as a predictive 
factor over time. These results confirm previous findings from cross-sectional research (28) 
and are in line with a substantial body of work suggesting that expectations make symptom 
perception in oneself more likely (24), at least partly because of the increased monitoring for 
symptoms that can occur as a result of increased expectation. To our knowledge, this is the 
first time the role of expectation has been demonstrated for the perception of side-effects in 
someone else, presumably as a result of a similar monitoring-related mechanism. 
Parents who thought that the NHS vaccination leaflet, health care workers or the media had 
suggested the vaccine causes side-effects were also more likely to report side-effects three 
days after vaccination. Surprisingly, when taking into account parental trust about the source 
of information, only suggestion from the health care worker remained significant. This 
indicates that parents’ immediate perception of side-effects may be influenced by the number 
and recent nature of suggestions of side-effects received, in line with the availability heuristic 
(60). The effect of suggestion from both the media and the NHS vaccination leaflet were 
mediated by direct expectation. Only suggestion of side-effects from the NHS vaccination 
leaflet was associated with side-effect reporting at one month, however, implying that while 
suggestions are important for immediate perception of symptoms, they may be less important 
in the longer-term recall of those symptoms.  
In terms of practical implications, these results suggest that reducing expectations may help 
limit the perception of side-effects. In particular, influential sources, such as the NHS 
vaccination leaflet and health care workers could aim to minimise their suggestion of the 
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incidence of side-effects. Although these sources have an obligation to inform patients about 
potentially serious adverse effects of medication, research has shown that the phrasing 
currently used by information sources causes people to substantially overestimate the 
likelihood of side-effects (9, 26). Our findings add weight to calls for this to be corrected 
(26).   
Interestingly, although learning and social observation are associated with the nocebo 
response (24), we found no effect of having seen other children experience side-effects from 
the vaccine or having previously perceived side-effects from vaccination in one’s own child, 
on reporting of side-effects. One possible reason for this may be that symptom perception is 
not happening in the self, as in previous research, but in one’s child. In this situation, parents 
are unable to access bodily cues and sensations, but must attend to and interpret their child’s 
behaviour (61). It is possible that social observation specifically affects bodily sensations.  
We also found a gender difference in perception of side-effects, with parents being more 
likely to report side-effects in boys than girls three days after vaccination. The reasons for 
this are unclear. In contrast to our results, one previous study found that three days following 
their child’s diphtheria, pertussis and tetanus vaccination, a higher proportion of mothers who 
contacted health care workers did so about their female child’s side-effects (62). However, 
these results may not be directly comparable, as they relate to parental behaviour in response 
to side-effects, rather than perception of side-effects per se (63). 
Exclusively associated with recall of side-effects at T3 were uncertainty-related beliefs such 
as believing the vaccine had not been tested enough and feeling that one did not know enough 
about the vaccine, as well as personality traits such as anxiety and pessimism. The effect of 
uncertainty-related beliefs and personality traits should be taken with caution as confidence 
intervals for the effect of the former were wide, and the effect sizes of the latter were small. 
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However, these results suggest that different factors are more influential for the medium-term 
recall of side-effects compared to the immediate perception of side-effects, and is consistent 
with findings that general negative affect is associated with negative memory bias (64). 
The perception that one’s child is particularly sensitive to medicines was also associated with 
recall of side-effects at T3. This effect was found to be mediated by direct expectation. 
Again, this is consistent with evidence suggesting that such perceptions can prompt people to 
monitor for evidence that is in line with their expectations (13). We also found evidence that 
a feedback loop might be in operation – parents who recalled symptoms at T3 also tended to 
have elevated perceptions of their child’s sensitivity to medicines. However, these results 
should be taken with caution as there was no longer an association when taking into account 
clustering by primary care practice. Whether this effect persists in the long term is unknown. 
Limitations 
Several limitations should be considered for this study. First, our sample may not be fully 
representative of the wider population of vaccinating parents. However, rates of side-effect 
perception identified in this study (43.2%) are close to those found in clinical trial data 
(47.9%) (46) and a previous demographically representative survey (41.0%) (9) suggesting 
that no systematic bias exists with regards to our main outcome. Our sample is mostly made 
up of mothers and we cannot say whether these findings would hold in a population of 
fathers. Second, not all potential predictors were measured at T1, due to time constraints as 
parents completed materials before their child’s vaccination appointment. However, only 
variables which should not change between time points, including demographics and 
personality traits, were asked at T2. Third, the interpretation of some results should be taken 
with caution due to low numbers and resulting wide confidence intervals. Results should be 
interpreted with caution due to the large number of analyses run, which increases the 
likelihood of type 1 errors. 
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Conclusions 
Our study suggests that in order to decrease side-effect perception and recall, and increase 
vaccination intention, parental expectations of side-effects following vaccination should be 
minimised, and that parents should be reassured about the generally mild nature of these side-
effects. This could be achieved through different avenues, but influential sources, such as the 
NHS vaccination leaflet and health care workers, should disseminate this message. By 
managing parents’ expectations about the incidence, severity and associated concern about 
side-effects, more parents may decide to re-vaccinate their child.  
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Table 1. Participants’ personal characteristics and associations with side-effect reporting 
Participant 
characteristics 
Level Side-effects recalled at T2 Side-effects recalled at T3 
Side-effects 
perceived 
No side-
effects 
perceived 
Adjusted odds ratio 
(95% CI)a 
Side-effects 
perceived 
No side-
effects 
perceived 
Adjusted odds ratio 
(95% CI)a 
Parent gender Male 
 
17 (40.5) 25 (59.5) 0.812 (0.309 to 2.133) 15 (41.7) 21 (58.3) 1.288 (0.465 to 3.563) 
Female 81 (43.8) 104 (56.2) Reference 57 (34.8) 107 (65.2) Reference 
Parent age 45+ 8 (50.0) 8 (50.0) 1.441 (0.426 to 4.876) 4 (30.8) 9 (69.2) 0.770 (0.193 to 3.066) 
35-44 41 (40.2) 61 (59.8) 1.007 (0.461 to 2.201) 34 (36.6) 59 (63.4) 1.068 (0.456 to 2.501) 
18-34 20 (39.2) 31 (60.8) Reference 15 (34.1) 29 (65.9) Reference 
Parent chronic illness Present  18 (36.7) 31 (63.3) 0.572 (0.231 to 1.416) 15 (34.1) 29 (65.9) 0.998 (0.389 to 2.563) 
None 72 (43.9) 92 (56.1) Reference 47 (35.3) 86 (64.7) Reference 
Other ‘at risk’ people 
in child’s household 
Yes 33 (40.7) 48 (59.3) 0.987 (0.472 to 2.064) 23 (34.3) 44 (65.7) 0.865 (0.390 to 1.916) 
No 50 (44.6) 62 (55.4) Reference 33 (35.5) 60 (64.5) Reference 
Child gender Male 56 (51.4) 53 (48.6) 2.232 (1.139 to 4.374)* 38 (38.0) 62 (62.0) 1.176 (0.570 to 2.429) 
Female 42 (35.9) 75 (64.1) Reference 34 (34.3) 65 (65.7) Reference 
First-born child Yes 53 (40.2) 79 (59.8) 0.783 (0.383 to 1.598) 35 (30.7) 79 (69.3) 0.914 (0.418 to 1.995) 
No 38 (46.3) 44 (53.7) Reference 27 (42.2) 37 (57.8) Reference 
Child age Range 1 
to 5 
N=98, 
M=3.04, 
SD=0.930 
N=127, 
M=3.13, 
SD=0.917 
0.921 (0.630 to 1.346) N=72, 
M=3.15, 
SD=1.016 
N=126, 
M=3.08, 
SD=0.900 
1.297 (0.873 to 1.927) 
Child chronic illness Present 9 (50.0) 9 (50.0) 2.250 (0.635 to 7.970) 6 (33.3) 12 (66.7) 0.965 (0.261 to 3.567) 
None 82 (41.8) 114 (58.2) Reference 56 (35.0) 104 (65.0) Reference 
Child up-to-date with 
other routine vaccines 
Not fully 
UTD 
5 (50.0) 5 (50.0) 1.157 (0.236 to 5.679) 3 (50.0) 3 (50.0) 1.418 (0.207 to 9.724) 
UTD 86 (42.6) 116 (57.4) Reference 59 (34.5) 112 (65.5) Reference 
a Adjusting for all other personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
*p≤.05 
Abbreviations. UTD = up-to-date 
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Table 2. Psychological predictors and associations with side-effect reporting 
Category Perception statement Level Side-effects recalled at T2 Side-effects recalled at T3 
Side-effects 
perceived 
No side-
effects 
perceived 
Adjusted 
odds ratio 
(95% CI)a 
Side-effects 
perceived 
No side-
effects 
perceived 
Adjusted 
odds ratio 
(95% CI)a 
Presence of pre-
existing symptoms 
Symptom in last 24 hrs No 59 (41.8) 82 (58.2) Reference 45 (37.5) 75 (62.5) Reference 
Yes 35 (44.3) 44 (55.7) 1.059 (0.501 
to 2.241) 
23 (31.1) 51 (68.9) 0.723 (0.321 
to 1.627) 
Direct measure of 
expectation 
Expectation for child to get side-effects  5 point Likert 
(‘very likely’ 
to ‘very 
unlikely’)  
N=98, 
M=3.13, 
SD=0.833  
N=128, 
M=2.62, 
SD=0.940 
2.085 (1.349 
to 3.221)* 
N=72, 
M=3.06, 
SD=0.870 
N=127, 
M=2.65, 
SD=0.972 
2.093 (1.325 
to 3.306)* 
Suggestion of 
symptoms - 
expectation 
Suggestion of causing side-effects – 
friends/family/relatives 
4 point Likert 
(‘very likely’ 
to ‘very 
unlikely’) 
N=61, 
M=2.44, 
SD=0.719 
N=83, M2.41, 
SD=0.750 
1.315 (0.730 
to 2.371) 
N=47, 
M=2.43, 
SD=0.773 
N=83, 
M=2.39, 
SD=0.746 
1.544 (0.796 
to 2.993) 
Suggestion of causing side-effects – Official 
websites/helplines/departments/agencies 
4 point Likert 
(‘very likely’ 
to ‘very 
unlikely’) 
N=65, 
M=2.09, 
SD=0.701 
N=94, 
M=2.12, 
SD=0.746 
1.366 (0.759 
to 2.458) 
N=44, 
M=2.18, 
SD=0.620 
N=96, 
M=2.05, 
SD=0.745 
1.803 (0.922 
to 3.526) 
Suggestion of causing side-effects – Media 4 point Likert 
(‘very likely’ 
to ‘very 
unlikely’) 
N=49, 
M=2.51, 
SD=0.794 
N=73, 
M=2.42, 
SD=0.865 
1.869 (1.011 
to 3.456)* 
N=34, 
M=2.53, 
SD=0.861 
N=72, 
M=2.38, 
SD=0.846 
1.635 (0.836 
to 3.197) 
Suggestion of causing side-effects – NHS 
vaccination leaflet 
4 point Likert 
(‘very likely’ 
to ‘very 
unlikely’) 
N=68, 
M=2.26, 
SD=0.745 
N=98, 
M=2.09, 
SD=0.801 
1.790 (1.018 
to 3.148)* 
N=45, 
M=2.33, 
0.739 
N=100, 
M=2.04, 
SD=0.790 
2.146 (1.139 
to 4.046)* 
Suggestion of causing side-effects – HCW 
suggestion in vaccine appointment 
4 point Likert 
(‘very likely’ 
to ‘very 
unlikely’) 
N=61, 
M=2.64, 
SD=0.708 
N=69, 
M=2.39, 
SD=0.691 
2.273 (1.152 
to 4.487)* 
N=41, 
M=2.61, 
SD=0.542 
N=69, 
M=2.42, 
SD=0.736 
1.703 (0.845 
to 3.430) 
Suggestion of causing side-effects – 
friends/family/relatives 
by Trust (range 
2 to 16) 
N=60, 
M=8.52, 
SD=3.192 
N=80, 
M=8.20, 
SD=2.826 
1.128 (0.977 
to 1.304) 
N=47, 
M=8.38, 
SD=3.274 
N=81, 
M=8.42, 
SD=2.974 
1.082 (0.932 
to 1.256) 
Suggestion of causing side-effects – Official 
websites/helplines/departments/agencies 
by Trust (range 
2 to 20) 
N=65, 
M=8.62, 
SD=3.436 
N=91, 
M=8.79, 
SD=3.501 
1.023 (0.910 
to 1.149) 
N=44, 
M=8.68, 
SD=3.483 
N=93, 
M=8.87, 
SD=3.630 
1.023 (0.899 
to 1.165) 
Suggestion of causing side-effects – Media by Trust (range 
2 to 20) 
N=49, 
M=8.14, 
SD=3.606 
N=70, 
M=7.56, 
SD=3.010 
1.130 (0.976 
to 1.309) 
N=34, 
M=8.00, 
SD=3.822 
N=69, 
M=7.83, 
SD=3.148 
1.046 (0.887 
to 1.233) 
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Suggestion of causing side-effects – NHS 
vaccination leaflet 
by Trust (range 
1 to 20) 
N=68, 
M=9.84, 
SD=3.831 
N=95, 
M=9.14, 
SD=3.869 
1.094 (0.978 
to 1.224) 
N=44, 
M=10.09, 
SD=4.022 
N=97, 
M=9.24, 
SD=3.960 
1.090 (0.967 
to 1.229) 
Suggestion of causing side-effects – HCW 
suggestion in vaccine appointment 
by Trust (range 
1 to 20) 
N=61, 
M=11.52, 
SD=3.581 
N=69, 
M=10.19, 
SD=3.919 
1.151 (1.016 
to 1.303)* 
N=41, 
M=11.29, 
SD=2.571 
N=69, 
M=10.38, 
SD=4.236 
1.074 (0.949 
to 1.214) 
Social observation 
- expectation 
Knowing another child with side-effects No 82 (42.5) 111 (57.5) Reference 61 (35.3) 112 (64.7) Reference 
Yes 16 (47.0) 18 (53.0) 1.546 (0.614 
to 3.889) 
11 (40.7) 16 (59.3) 2.041 (0.763 
to 5.462) 
Severity of side-effects observed in other 
children 
5 point Likert 
(‘very mild to 
very severe’) 
N=16, 
M=2.06, 
SD=0.680 
N=18, 
M=2.06, 
SD=0.539 
2.240 (0.197 
to 25.486) 
N=11, 
M=2.09, 
SD=0.302 
N=16, 
M=1.94, 
SD=0.443 
3.344 (0.021 
to 525.680) 
Previous symptoms 
following 
vaccination 
CHILD having side-effects from flu vaccine 
previously 
No 27 (43.5) 35 (56.5) Reference 18 (29.0) 44 (71.0) Reference 
Yes 9 (37.5) 15 (62.5) 0.840 (0.219 
to 3.229) 
8 (36.4) 14 (63.6) 2.097 (0.541 
to 8.134) 
Worry about CHILD’s previous side-effects 4 point Likert 
(‘not at all’ to 
‘very worried’)  
N=9, 
M=1.78, 
SD=0.667 
N=15, 
M=1.60, 
SD=0.828 
† N=8, 
M=1.88, 
SD=0.641 
N=14, 
M=1.64, 
SD=0.929 
† 
Severity of CHILD’s previous side-effects 5 point Likert 
(‘very mild’ to 
‘very severe’) 
N=9, 
M=1.89, 
SD=0.601 
N=15, 
M=1.33, 
SD=0.488 
† N=8, 
M=1.75, 
SD=0.463 
N=14, 
M=1.29, 
SD=0.469 
16.704 
(0.446 to 
626.152) 
CHILD side-effect from other routine vaccines No 37 (34.9) 69 (65.1) Reference 27 (28.4) 68 (71.6) Reference 
Yes 49 (50.5) 48 (49.5) 2.103 (0.997 
to 4.434) 
34 (40.5) 50 (59.5) 1.842 (0.807 
to 4.206) 
Worry about side-effect from other routine 
vaccine 
4 point Likert 
(‘not at all’ to 
‘very worried’) 
N=49, 
M=1.82, 
SD=0.697 
N=48, 
M=1.75, 
SD=0.601 
0.915 (0.369 
to 2.267) 
N=34, 
M=1.75, 
SD=0.463 
N=50, 
M=1.64, 
SD=0.598 
2.747 (0.975 
to 7.738) 
Psychological traits Neuroticism (EPQR-A) Range 0 to 6 N=91, 
M=1.54, 
SD=1.377 
N=120, 
M=1.72, 
SD=1.685 
0.940 (0.755 
to 1.170) 
N=62, 
M=1.69, 
SD=1.421 
N=114, 
M=1.64, 
SD=1.652 
1.050 (0.830 
to 1.328) 
Positive affect (PANAS) Range 5 to 22 N=88, 
M=15.39, 
SD=3.978 
N=119, 
M=15.32, 
SD=3.505 
0.946 (0.862 
to 1.038) 
N=62, 
M=14.90, 
SD=4.179 
N=113, 
M=15.51, 
SD=3.368 
0.933 (0.846 
to 1.029) 
Negative affect (PANAS) Range 5 to 18 N=88, 
M=7.92, 
SD=2.780 
N=119, 
M=7.45, 
SD=2.727 
1.051 (0.929 
to 1.188) 
N=62, 
M=7.77, 
SD=2.439 
N=113, 
M=7.58, 
SD=2.856 
1.024 (0.889 
to 1.166) 
Anxiety (STAI-T) Range 6 to 19 N=91, 
M=12.47, 
SD=2.651 
N=120, 
M=12.87, 
SD=2.634 
0.993 (0.861 
to 1.146) 
N=62, 
M=13.08, 
SD=2.491 
N=114, 
M=12.67, 
SD=2.523 
1.192 (1.011 
to 1.406)* 
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Optimism (LOT-R) Range 1 to 12 N=85, 
M=7.53, 
SD=1.817 
N=115, 
M=7.26, 
SD=1.920 
0.942 (0.783 
to 1.134) 
N=61, 
M=7.30, 
SD=1.856 
N=111, 
M=7.40, 
SD=1.997 
0.843 (0.688 
to 1.032) 
Pessimism (LOT-R) Range 0 to 12 N=85, 
M=4.29, 
SD=2.109 
N=115, 
M=4.18, SD= 
2.134 
1.147 (0.966 
to 1.363) 
N=61, 
M=4.51, 
SD=1.776 
N=111, 
M=3.89, 
SD=2.213 
1.254 (1.035 
to 1.518)* 
Perceptions about 
medicines and 
other technologies 
Perceived sensitivity to Medicines at T1 (PSM 
– T1) 
Range 5 to 25 N=98, 
M=10.48, 
SD=3.253 
N=129, 
M=9.40, 
SD=3.404 
1.074 (0.970 
to 1.189) 
N=72, 
M=10.51, 
SD=2.722 
N=128, 
M=9.30, 
SD=3.476 
1.150 (1.030 
to 1.285)* 
Modern Health Worries (MHW)  Range 28 to 
126 
N=88, 
M=67.32, 
SD=22.696 
N=118, 
M=67.53, 
SD=20.288 
0.987 (0.969 
to 1.005) 
N=62, 
M=68.34, 
M=21.907 
N=113, 
M=66.25, 
SD=19.386 
1.004 (0.985 
to 1.024) 
Beliefs about Medicines Questionnaire-
general, harm subscale (BMQ-GH) 
Range 4 to 20 N=91, 
M=8.73, 
SD=2.539 
N=121, 
M=8.59, 
SD=2.728 
1.016 (0.889 
to 1.161) 
N=62, 
M=8.55, 
SD=2.559 
N=115, 
M=8.45, 
SD=2.722 
1.015 (0.881 
to 1.169) 
Beliefs about Medicines Questionnaire-
general, overuse subscale (BMQ-GO) 
Range 5 to 19 N=91, 
M=10.84, 
SD=2.391 
N=121, 
M=10.72, 
SD=2.742 
1.032 (0.905 
to 1.176) 
N=62, 
M=10.79, 
SD=2.593 
N=115, 
M=10.49, 
SD=2.716 
1.079 (0.939 
to 1.240) 
a Adjusting for all personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
*p≤.05 
† Adjusted calculations unable to be run due to lack of cases in some groups. 
Abbreviations. NHS = National Health Service, HCW = health care worker  
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Table 3. General attitudes and associations with side-effect reporting 
Perception statement Level Side-effects recalled at T2 Side-effects recalled at T3 
Side-
effects 
perceived 
No side-
effects 
perceived 
Adjusted odds ratio 
(95% CI)a 
Side-
effects 
perceived 
No side-
effects 
perceived 
Adjusted odds ratio 
(95% CI) a 
The child flu vaccine 
has not been tested 
enough for me to feel it 
is safe 
Agree 9 (60.0) 6 (40.0) 1.188 (0.248 to 
5.690) 
8 (66.7) 4 (33.3) 6.466 (1.083 to 
38.586)* 
Disagree 58 (40.0) 87 (60.0) Reference 42 (30.2) 97 (69.8) Reference 
The child flu vaccine 
can cause unpleasant 
short-term side-effects 
Agree 23 (57.5) 17 (42.5) 1.549 (0.566 to 
4.235) 
11 (36.7) 19 (63.3) 1.354 (0.438 to 4.184) 
Disagree 36 (39.6) 55 (60.4) Reference 26 (28.6) 65 (71.4) Reference 
The child flu vaccine 
can cause long-term 
health problems 
Agree 1 (50.0) 1 (50.0) 0.000 (†) 2 (66.7) 1 (33.3) † 
Disagree 72 (42.9) 96 (57.1) Reference 48 (31.4) 105 (68.6) Reference 
The child flu vaccine 
does not suit my 
religious or cultural 
beliefs/values 
Agree 6 (85.7) 1 (14.3) 4.811 (0.464 to 
49.858) 
3 (75.0) 1 (25.0) 2.043 (0.115 to 36.171) 
Disagree 76 (42.2) 104 (57.8) Reference 53 (32.3) 111 (67.7) Reference 
I don’t like [child] 
having vaccinations in 
general 
Agree 6 (75.0) 2 (25.0) 2.926 (0.393 to 
21.762) 
3 (60.0) 2 (40.0) 4.227 (0.320 to 55.808) 
Disagree 81 (44.5) 101 (55.5) Reference 61 (37.7) 101 (62.3) Reference 
I don’t know enough 
about the child flu 
vaccine 
Agree 24 (49.0) 25 (51.0) 1.414 (0.555 to 
3.605) 
20 (50.0) 20 (50.0) 3.014 (1.033 to 8.797)* 
Disagree 48 (44.9) 59 (55.1) Reference 36 (35.3) 66 (64.7) Reference 
The vaccination 
campaign is just about 
making money for the 
manufacturers 
Agree 3 (42.9) 4 (57.1) 0.275 (0.014 to 
5.229) 
4 (66.7) 2 (33.3) 4.940 (0.367 to 66.515) 
Disagree 73 (43.2) 96 (56.8) Reference 52 (32.9) 106 (67.1) Reference 
The flu vaccine would 
interact with other 
medications that 
[Specified Child]  is 
currently taking 
Agree 0  0 † 1 (100.0) 0 (0.0) † 
Disagree 129 (59.2) 89 (40.8) Reference 52 (34.4) 99 (65.6) Reference 
Vaccinating [Specified 
Child] against flu each 
year will overload 
his/her immune system 
Agree 9 (69.2) 4 (30.8) 1.377 (0.267 to 
7.095) 
5 (50.0) 5 (50.0) 2.363 (0.417 to 13.388) 
Disagree 72 (41.9) 100 (58.1) Reference 53 (33.8) 104 (66.2) Reference 
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Vaccinating [child] 
against flu each year is 
too much of an ongoing 
time commitment 
Agree 3 (33.3) 6 (66.7) 1.161 (0.146 to 
9.220) 
2 (28.6) 5 (71.4) 1.099 (0.088 to 13.705) 
Disagree 82 (42.7) 110 (57.3) Reference 64 (37.0) 109 (63.0) Reference 
Having the child flu 
vaccine is an effective 
way of preventing 
[Specified Child] from 
catching flu 
Agree 81 (43.3) 106 (56.7) 0.673 (0.173 to 
2.612) 
63 (37.0) 107 (63.0) 2.455 (0.481 to 12.531) 
Disagree 7 (46.6) 8 (53.3) Reference 3 (23.1) 10 (76.9) Reference 
If I don’t vaccinate 
[child], then [child] is 
likely to catch flu 
Agree 28 (52.8) 25 (47.2) 1.198 (0.477 to 
3.006) 
23 (44.2) 29 (55.8) 1.858 (0.688 to 5.018) 
Disagree 33 (45.2) 40 (54.8) Reference 18 (30.0) 42 (70.0) Reference 
Flu would be a serious 
illness for child 
Agree 55 (40.4) 81 (59.6) 0.705 (0.254 to 
1.954) 
41 (33.9) 80 (66.1) 0.896 (0.303 to 2.647) 
Disagree 14 (41.2) 20 (58.8) Reference 8 (32.0) 17 (68.0) Reference 
Flu would be a serious 
illness for self 
Agree 42 (41.2) 60 (58.8) 0.821 (0.348 to 
1.940) 
32 (36.4) 56 (63.6) 1.377 (0.536 to 3.534) 
Disagree 24 (42.1) 33 (57.9) Reference 12 (27.3) 32 (72.7) Reference 
Flu would be a serious 
illness for someone in 
child’s household 
Agree 54 (44.3) 68 (55.7) 1.094 (0.456 to 
2.621) 
38 (36.2) 67 (63.8) 1.108 (0.426 to 2.883) 
Disagree 18 (38.3) 29 (61.7) Reference 11 (31.4) 24 (68.6) Reference 
If [child] were to catch 
flu, how much, if at all, 
would it impact your 
daily life? 
4 point 
Likert (‘not 
at all’ to ‘a 
great extent’) 
N=91, 
M=3.41, 
SD=0.683 
N=122, 
M=3.41, 
SD=0.586 
0.915 (0.514 to 
1.628) 
N=162, 
M=3.339, 
SD=0.636 
N=115, 
M=3.50, 
SD=0.598 
0.814 (0.441 to 1.500) 
a Adjusting for all personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
*p≤.05 
† Adjusted calculations unable to be run due to lack of cases in some groups  
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Table 4. Mediation analyses for effect of direct expectation as a mediator on perception of side-effects at T2 and T3 
Independent Variable Mediator Dependent Variable Total indirect effect 
(95% CI)a 
Direct effect 
(95% CI) 
Total effect 
(95% CI)a 
Proportion of effect 
mediated 
Suggestion of causing side-effects – 
Media 
Direct 
expectation 
Side-effects 
recalled at T2 
.103 (.005 to 0.251)* .158 (-.196 to 
.408) 
.261 (-.092 to 
.496) 
39.48% 
Suggestion of causing side-effects – NHS 
vaccination leaflet 
Direct 
expectation 
Side-effects 
recalled at T2 
.143 (.033 to .307)* .080 (-.220 to 
.368) 
.223 (-.054 to 
.467) 
64.14% 
Suggestion of causing side-effects – NHS 
vaccination leaflet 
Direct 
expectation 
Side-effects 
recalled at T3 
.095 (-.039 to .273) .208 (-.106 to 
.474) 
.304 (.026 to 
.542)* 
Not significant 
Perceived sensitivity to Medicines at T1 
(PSM – T1) 
Direct 
expectation 
Side-effects 
recalled at T3 
.098 (.020 to .210)* .170 (-.050 to 
.380) 
.269 (.060 to 
.460)* 
36.61% 
Pessimism (LOT-R) Direct 
expectation 
Side-effects 
recalled at T3 
.038 (-.014 to .125) .210 (-.057 to 
.406) 
.248 (-.018 to 
.447) 
Not significant 
a Adjusting for all personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
*p≤.05 
Abbreviations. NHS = National Health Service  
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Table 5. Participants’ personal characteristics and associations with intention to vaccinate 
Participant characteristics Level Intention to vaccinate child next flu season 
Do not intend to vaccinate Intend to vaccinate Adjusted odds ratio (95% CI)a 
Parent gender Female 38 (19.0) 162 (81.0) 0.397 (0.078 to 2.004) 
Male 2 (4.5) 42 (95.5) Reference 
Parent age 45+ 1 (6.3) 15 (93.8) 5.277 (0.587 to 47.468) 
35-44 17 (16.5) 86 (83.5) 2.932 (1.049 to 8.196)* 
18-34 12 (23.1) 40 (76.9) Reference 
Parent chronic illness Present  7 (14.0) 43 (86.0) 2.289 (0.562 to 9.325) 
None 30 (18.2) 135 (81.8) Reference 
Other ‘at risk’ people in child’s household Yes 14 (17.3) 67 (82.7) 0.597 (0.221 to 1.617) 
No 15 (13.2) 99 (86.8) Reference 
Child gender Female 21 (16.4) 107 (83.6) 1.714 (0.665 to 4.420) 
Male 18 (15.7) 97 (84.3) Reference 
First-born child Yes 23 (17.3) 110 (82.7) 0.776 (0.279 to 2.160) 
No 14 (16.9) 69 (83.1) Reference 
Child age Range 1 to 5 N=39, M=3.23, SD=1.038 N=203, M=3.07, SD=0.890 0.725 (0.432 to 1.216) 
Child chronic illness Present 2 (11.1) 16 (88.9) 2.389 (0.241 to 23.669) 
None 35 (17.7) 163 (82.3) Reference 
Child up-to-date with other routine vaccines Not fully UTD 1 (10.0) 9 (90.0) 1.421 (0.149 to 13.588) 
UTD 36 (17.6) 168 (82.4) Reference 
a Adjusting for all other personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
*p≤.05 
Abbreviations: UTD = up-to-date 
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Table 6. Associations between variables and intention to vaccinate 
Category Perception statement Level Intention to vaccinate child next flu season 
Do not intend to 
vaccinate 
Intend to vaccinate Adjusted odds ratio 
(95% CI)a 
Symptoms following 
vaccination 
Presence of side-effects as recalled 
at T2 
Yes 21 (21.4) 77 (78.6) 0.627 (0.242 to 1.622) 
No 17 (13.2) 112 (86.8) Reference 
Worry about side-effects as recalled 
at T2 
4 point Likert (‘not at all’ to ‘very 
worried’) 
N=21, M=2.19, 
SD=1.030 
N=79, M=1.49, 
SD=0.575 
0.258 (0.076 to 0.874)* 
Severity of side-effects as recalled 
at T2 
5 point Likert (‘very mild’ to ‘very 
severe’) 
N=21, M=2.48, 
SD=0.873 
N=79, M=1.70, 
SD=0.790 
0.110 (0.020 to 0.598)* 
Presence of side-effects as recalled 
at T3 
Yes 16 (22.2) 56 (77.8) 0.272 (0.090 to 0.825)* 
No 13 (10.2) 115 (89.8) Reference 
Worry about side-effects as recalled 
at T3 
4 point Likert (‘not at all’ to ‘very 
worried’) 
N=15, M=2.00, 
SD=0.926 
N=55, M=1.55, 
SD=0.662 
0.165 (0.029 to 0.923)* 
Severity of side-effects as recalled 
at T3 
5 point Likert (‘very mild’ to ‘very 
severe’) 
N=14, M=2.29, 
SD=0.914 
N=52, M=1.75, 
SD=0.789 
0.310 (0.084 to 1.144) 
Psychological predictors HCW suggestion in vaccine 
appointment 
4 point Likert (‘very likely’ to ‘very 
unlikely’) 
N=21, M=2.48, 
SD=0.873 
N=111, M=2.50, 
SD=0.686 
1.821 (0.670 to 4.950) 
HCW suggestion in vaccine 
appointment 
Suggestion by Trust, range 1 to 20 N=21, M=9.57, 
SD=5.316 
N=11, M=10.97, 
SD=3.528 
1.297 (1.052 to 1.598)* 
Change in perceived sensitivity to 
medicines 
Range -20 to 8 N=28, M=-0.18, 
SD=2.749 
N=166, M=-0.33, 
SD=3.449 
1.002 (0.868 to 1.170) 
a Adjusting for all personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines) 
*p≤.05 
Abbreviations: HCW = health care worker 
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Table 7. Associations between reporting side-effects at T2 and T3 and parents’ perceived sensitivity of their child to medicines 
Side-effect 
reporting 
Level Perceived sensitivity to medicines      
N, mean, SD Adjusted Ba Standard Error 
B 
β t p Adjusted R2 
Side-effects recalled 
at T2 
Side-effects 
perceived 
N=73, M=-0.29, 
SD=3.10 
0.422 0.533 .061 0.793 .430 .291 
No side-effects 
perceived 
N=104, M=-0.28, 
SD=3.33 
Reference      
Side-effects recalled 
at T3 
Side-effects 
recalled 
N=71, M=-0.47, 
SD=3.40 
1.466  0.526 .204 2.786 .006* .342 
No side-effects 
recalled 
N=123, M=-0.01, 
SD=3.27 
Reference      
a Adjusting for all personal characteristics (both parent and child, apart from child up-to-date vaccine status for other routine vaccines, and 
perceived sensitivity to medicines at T1) 
*p≤.05 
